Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Assis

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Clinics in Liver Disease|September 28, 2018
Chronic Complications of Cholestasis: Evaluation and ManagementDavid N Assis
Current Opinion in Gastroenterology|February 5, 2026
Current opinion in gastroenterologyDavid N Assis
Clinical Liver Disease|April 8, 2020
Immunopathogenesis of Autoimmune HepatitisDavid N Assis
The New England Journal of Medicine|February 21, 2024
Advancing Second-Line Treatment for Primary Biliary CholangitisDavid N Assis
Hepatology (Baltimore, Md.)|January 6, 2021
Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled TrialsDavid N Assis, Cynthia Levy
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 8, 2017
Gallbladder and bile duct disease in Cystic FibrosisDavid N Assis, Dominique Debray
Clinics in Chest Medicine|February 10, 2016
Gastrointestinal Disorders in Cystic FibrosisDavid N Assis, Steven D Freedman
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 21, 2023
Recent Advances in the Management of Primary Sclerosing CholangitisDavid N Assis, Christopher L Bowlus
Clinics in Liver Disease|July 16, 2025
Hepatotoxicity of Chemotherapy and Immune Checkpoint InhibitorsPeter D Block, David N Assis
Journal of Hepatology|November 6, 2025
Phase II clinical trials in primary sclerosing cholangitis: Making the most of every opportunity?David N Assis, Johannes R Hov
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Clinics in Liver Disease|September 28, 2018
Chronic Complications of Cholestasis: Evaluation and ManagementDavid N Assis
Current Opinion in Gastroenterology|February 5, 2026
Current opinion in gastroenterologyDavid N Assis
Clinical Liver Disease|April 8, 2020
Immunopathogenesis of Autoimmune HepatitisDavid N Assis
The New England Journal of Medicine|February 21, 2024
Advancing Second-Line Treatment for Primary Biliary CholangitisDavid N Assis
Hepatology (Baltimore, Md.)|January 6, 2021
Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled TrialsDavid N Assis, Cynthia Levy
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 8, 2017
Gallbladder and bile duct disease in Cystic FibrosisDavid N Assis, Dominique Debray
Clinics in Chest Medicine|February 10, 2016
Gastrointestinal Disorders in Cystic FibrosisDavid N Assis, Steven D Freedman
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 21, 2023
Recent Advances in the Management of Primary Sclerosing CholangitisDavid N Assis, Christopher L Bowlus
Clinics in Liver Disease|July 16, 2025
Hepatotoxicity of Chemotherapy and Immune Checkpoint InhibitorsPeter D Block, David N Assis
Journal of Hepatology|November 6, 2025
Phase II clinical trials in primary sclerosing cholangitis: Making the most of every opportunity?David N Assis, Johannes R Hov
Pageof 6